This is an aggregated industry headline. Read the full story at FiercePharma →
As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiative that could allow the Trump administration to impose restrictions on its use, The Wall Street Journal reports.
By FiercePharma
· Jun 8, 2026
· via FiercePharma
Image: FiercePharma
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
The former quarterback spoke with Fierce Pharma Marketing on teaming up with ARS, his journey with food allerg…
The WeekFierceBiotech ↗
Australian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the U.S.- but up to a fifth of the…
The WeekBriefing
FDA clears GSK’s Jideytro, the company’s first lung cancer drug, marking a swift return on its $10.6B Nuvalent…